Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Haemonetics makes the machines, disposable kits, and software that blood and plasma centers use to collect and process donations, plus tools hospitals use to manage transfusions and control bleeding.
Haemonetics makes the equipment that turns a volunteer's arm into a reliable supply of blood and plasma. Its machines sit in donation centers, spinning and separating blood into its parts — red cells, platelets, plasma — so a single donation can help several patients. The company also sells the single-use disposable kits that go with each machine, which is the quiet engine of the business: the machines get installed once, but the kits get used up every single day.
Donation centers and plasma collection companies are the core customers, and they buy from Haemonetics because the gear has to be precise and dependable — a botched draw wastes a donor's time and a scarce resource. Haemonetics also sells donor management software that tracks who gave what and when, and it serves hospitals with technology for storing blood safely and for transfusion and hemostasis, which is the tricky business of stopping bleeding during and after surgery. The company is based in Boston, and it has grown partly by buying its way into new corners of blood management rather than inventing everything itself. That strategy cuts both ways: acquisitions bring new products and customers fast, but they also pile on debt and demand careful integration. Plasma collection has been a particularly important growth area, tied to the booming market for therapies made from plasma, and swings in that market ripple straight through to Haemonetics.
The clearest way to judge this business is by the recurring kit sales and the installed base of machines — a boring but powerful combination, like razors and blades. It is a real, necessary business serving hospitals and blood banks, but it is not a rocket ship: it depends on donation volumes, hospital budgets, and the health of the plasma industry, all of which can move around from year to year.
Saved answer · last researched 15 Nov 2026